vs
Side-by-side financial comparison of Dexcom (DXCM) and FIRST HORIZON CORP (FHN). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $888.0M, roughly 1.4× FIRST HORIZON CORP). FIRST HORIZON CORP runs the higher net margin — 29.4% vs 21.2%, a 8.2% gap on every dollar of revenue. On growth, FIRST HORIZON CORP posted the faster year-over-year revenue change (21.8% vs 21.6%). Over the past eight quarters, FIRST HORIZON CORP's revenue compounded faster (20.0% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
DXCM vs FHN — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $888.0M |
| Net Profit | $267.3M | $261.0M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 38.5% |
| Net Margin | 21.2% | 29.4% |
| Revenue YoY | 21.6% | 21.8% |
| Net Profit YoY | 153.6% | 57.2% |
| EPS (diluted) | $0.67 | $0.51 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $888.0M | ||
| Q3 25 | $1.2B | $889.0M | ||
| Q2 25 | $1.2B | $830.0M | ||
| Q1 25 | $1.0B | $812.0M | ||
| Q4 24 | $1.1B | $729.0M | ||
| Q3 24 | $994.2M | $827.0M | ||
| Q2 24 | $1.0B | — |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $261.0M | ||
| Q3 25 | $283.8M | $262.0M | ||
| Q2 25 | $179.8M | $241.0M | ||
| Q1 25 | $105.4M | $218.0M | ||
| Q4 24 | $151.7M | $166.0M | ||
| Q3 24 | $134.6M | $218.0M | ||
| Q2 24 | $143.5M | — |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 38.5% | ||
| Q3 25 | 20.1% | 38.7% | ||
| Q2 25 | 18.4% | 37.2% | ||
| Q1 25 | 12.9% | 35.1% | ||
| Q4 24 | 17.0% | 28.8% | ||
| Q3 24 | 15.3% | 34.0% | ||
| Q2 24 | 15.7% | — |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 29.4% | ||
| Q3 25 | 23.5% | 29.5% | ||
| Q2 25 | 15.5% | 29.0% | ||
| Q1 25 | 10.2% | 26.8% | ||
| Q4 24 | 13.6% | 22.8% | ||
| Q3 24 | 13.5% | 26.4% | ||
| Q2 24 | 14.3% | — |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.51 | ||
| Q3 25 | $0.70 | $0.50 | ||
| Q2 25 | $0.45 | $0.45 | ||
| Q1 25 | $0.27 | $0.41 | ||
| Q4 24 | $0.37 | $0.29 | ||
| Q3 24 | $0.34 | $0.40 | ||
| Q2 24 | $0.35 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $8.8B |
| Total Assets | $6.3B | $83.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $8.8B | ||
| Q3 25 | $2.7B | $8.9B | ||
| Q2 25 | $2.6B | $9.0B | ||
| Q1 25 | $2.3B | $8.7B | ||
| Q4 24 | $2.1B | $8.8B | ||
| Q3 24 | $2.0B | $9.0B | ||
| Q2 24 | $2.4B | — |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $83.9B | ||
| Q3 25 | $7.5B | $83.2B | ||
| Q2 25 | $7.3B | $82.1B | ||
| Q1 25 | $6.8B | $81.5B | ||
| Q4 24 | $6.5B | $82.2B | ||
| Q3 24 | $6.4B | $82.6B | ||
| Q2 24 | $6.8B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $396.0M |
| Free Cash FlowOCF − Capex | — | $389.0M |
| FCF MarginFCF / Revenue | — | 43.8% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | — | 1.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $595.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $396.0M | ||
| Q3 25 | $659.9M | $-200.0M | ||
| Q2 25 | $303.0M | $83.0M | ||
| Q1 25 | $183.8M | $349.0M | ||
| Q4 24 | $301.4M | $191.0M | ||
| Q3 24 | $199.5M | $389.0M | ||
| Q2 24 | $279.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $389.0M | ||
| Q3 25 | $579.4M | $-208.0M | ||
| Q2 25 | $208.9M | $74.0M | ||
| Q1 25 | $96.8M | $340.0M | ||
| Q4 24 | $176.8M | $174.0M | ||
| Q3 24 | $88.3M | $383.0M | ||
| Q2 24 | $213.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 43.8% | ||
| Q3 25 | 47.9% | -23.4% | ||
| Q2 25 | 18.1% | 8.9% | ||
| Q1 25 | 9.3% | 41.9% | ||
| Q4 24 | 15.9% | 23.9% | ||
| Q3 24 | 8.9% | 46.3% | ||
| Q2 24 | 21.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 0.8% | ||
| Q3 25 | 6.7% | 0.9% | ||
| Q2 25 | 8.1% | 1.1% | ||
| Q1 25 | 8.4% | 1.1% | ||
| Q4 24 | 11.2% | 2.3% | ||
| Q3 24 | 11.2% | 0.7% | ||
| Q2 24 | 6.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.52× | ||
| Q3 25 | 2.33× | -0.76× | ||
| Q2 25 | 1.69× | 0.34× | ||
| Q1 25 | 1.74× | 1.60× | ||
| Q4 24 | 1.99× | 1.15× | ||
| Q3 24 | 1.48× | 1.78× | ||
| Q2 24 | 1.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
FHN
| Commercial Consumer And Wealth Segment | $776.0M | 87% |
| Other | $88.0M | 10% |
| Corporate | $24.0M | 3% |
